Tag: Year
Ironwood names proxy brawler Denner to its board a year after...
In the bareknuckle world of activist investors, Alex Denner, a former protégé of Carl Icahn, has made his name sparring with pharmaceutical companies. More than...
Lonza plots $93M expansion to capsule manufacturing, adding billions of doses...
When CDMO Lonza shelled out $5.5 billion for capsule-maker Capsugel in 2017, it made a big bet the booming capsule market would drive revenue....
2020 may be the year from hell, but health tech IPO...
On top of the ongoing Covid-19 pandemic, 2020 has been punctuated by devastation: raging wildfires, record unemployment and growing inequality. But despite all of...
AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just...
AstraZeneca, advancing a COVID-19 vaccine from the University of Oxford, is among global frontrunners in the worldwide hunt for a viable vaccine. Now, the drugmaker’s CEO...
Teva CEO Kåre Schultz nabs whopping $33M in first full year...
If you thought Teva had gone big-time with its 2017 pay package for CEO Kåre Schultz, check out what it paid him in 2018.
The...
Teva forecasts worse-than-expected ‘trough year’ as generics hammer MS drug Copaxone
Shares of Teva fell nearly 12% in pre-market trading to $16.80 after the company’s executives conceded during the fourth-quarter earnings report that 2019 would...
